By Warren A. Weinberg, M.D.; Caryn R. Harper, M.S.; Graham J. Emslie, M.D., Southwestern Medical Center, Dallas, Texas; Roger A. Brumback, MD., University of Oklahoma School of Medicine, Oklahoma City, Oklahoma
Depression is a leading cause of failure in school and in life for young people (children, adolescents, and young adults) with learning disabilities. The depressed state can be primary (familial-genetic disorder) or secondary (symptomatic depression) to medical conditions or learning disability.
Depression is feeling sad, lonely, unloved, dumb, and worthless, along with guilt feelings and beliefs of being mistreated. Depression is having trouble falling asleep (initial insomnia), restless sleep with recurrent awakenings (interval insomnia), or waking early in the morning unable to fall back to sleep (terminal insomnia). Depression often is also awakening in the morning anxious, tired, sad, or mad. Depression is a loss of interest in friends, hobbies, and school or work. Depression causes a loss of concentration, poor memory, forgetfulness, and inattention. Depression is having headaches, stomachaches, and other physical symptoms. Depression is feeling angry, picked on, grouchy, and irritable. Sometimes depression is feeling hopeless and helpless, and wishing to die. Depression is the leading cause of suicide. A clinical depression is a combination of these symptoms which persist for longer than three weeks and cause failure in the person’s environments of home, work (school), or play. Depression has been demonstrated in many studies to be associated with and the possible cause of school failure, conduct disorder and delinquency, anorexia and bulimia, school phobia, and panic attacks.
The scientific description of depression and manic-depressive disease was first prepared by Emil Kraepelin in the early 1900s. For the first half of the twentieth century, most clinicians did not accept the concept that primary depression (or manic-depressive disease: affective illness) occurred in children and adolescents. However, by the early 1970s, criteria for the recognition of depression in children and adolescents had been established (Table 1, “The Weinberg Criteria”). These criteria were based upon those used to diagnose depression and mania in adults as formulated in the Research Diagnostic Criteria (RDC) for adult psychiatric disorders by the Department of Psychiatry of the Washington University School of Medicine in St. Louis, Missouri. The Weinberg Criteria for depression in children and adolescents was published in 1973 and the criteria for mania in 1976 by Weinberg and Brumback (Table 2). In 1980, the American Psychiatric Association published the Diagnostic and Statistical Manual of Mental Disorders - Third Edition (DSM-III) [revised in 1988 as DSM-IIIR and in 1994 as DSM-IV] which contained guidelines for the diagnosis of depression and mania in individuals of all ages. In the DSM-III, diagnostic criteria were added for the various temporal patterns of affective illness. These patterns are characterized by chronic, long-standing ebbs and flows, “good” and “bad” periods per day, mixed with “good” and “bad” days, but without prolonged well (stable) states. Patterns of affective illness with prominent manic symptomatology (chronic hypomania, cyclothymia, juvenile rapid cycling bipolar disorder and dysthymia with the manic feature of hostile anger) are most prevalent in pre-school years and continue through young adult age.
Depression and other forms of affective illness are probably genetic disorders based upon studies of familial clusterings, evaluation of offspring of both depressed and manic-depressive adults, and studies of siblings and twins reared apart. Research is now underway to determine whether the various patterns of affective illness represent a unitary genetic disorder modified by other traits or are the result of multiple and varied genetic and psychosocial causes. It is possible that even genetically-based affective illness could remain dormant throughout an individual’s life if inappropriate environmental stressors are not present.
The “Weinberg Criteria” for depression (Table 1), include 10 major symptom categories: dysphoric mood, self-deprecatory ideation, agitation, sleep disturbance, change in school performance, diminished socialization, change in attitude towards school, somatic complaints, loss of usual energy, and unusual change in appetite or weight. The individual must manifest: 1) dysphoric moods and affect and 2) self-deprecatory ideation. We use the term mood to describe the young person’s emotional feelings, while the term affect indicates the individual’s appearance in relation to feelings. Symptoms of dysphoric mood and affect are sadness, loneliness, unhappiness, hopelessness, pessimism, mood swings, moodiness, irritability, easily annoyed, hypersensitivity, tearfulness and crying, negativity, and difficulty being pleased. Generally, a child manifesting dysphoric moods will have a multitude of these symptoms. Sadness and hopelessness can be so severe that the young person will withdraw to a room to sit and cry (melancholy). Self-deprecation is the feeling of being worthless, useless, dumb, stupid, and guilty, or beliefs of persecution. Death wishes occur in 35% of pre-pubertal children manifesting depression, suicidal ideation (thoughts and plans) in 15%, and suicidal attempts in 5%.
In addition to dysphoric moods and self-deprecation, the child must have four or more of the following eight symptoms:
agitation
sleep disturbance
change in school performance
diminished socialization
change in attitude toward school (work)
somatic complaints
loss of usual energy
unusual change in appetite or weight
Most young people fulfilling this criteria will have seven or eight of the ten major symptoms.
The agitation of depression is irritability, grouchy feelings and actions, inappropriate sudden anger or fighting, quarrelsomeness, lack of respect for authority, and difficulty getting along with others. The most common sleep disturbance is trouble falling asleep (initial insomnia). The young child will often manifest restless sleep with frequent awakenings (interval insomnia) and enter the parents bed for comfort. Awakening too early in the morning (terminal insomnia) strongly correlates with thoughts of suicide. Common to the depressed adolescent is difficulty awakening in the morning with excessive morning sleep. Change in school performance is characterized by frequent complaints from the teachers of: daydreaming, poor concentration and memory, and inattentiveness; loss of usual work effort in school subjects with a drop in grades; loss of usual interest in extra-scholastic activities; incomplete classroom assignments; much incomplete homework; avoidance of homework activity; and disruptive behavior.
The depressed young person will often lose interest in friends and social activities. Occasionally the young person loses the ability to anticipate or experience pleasure (anhedonia). Commonly, the individual must be forced or coerced to participate in what previously were usual, fun activities, but the enjoyment is lessened and the participation does not restore interest (dyshedonia). School avoidance, school resistance, discomfort in school, and school phobia are symptomatic of depression. Somatic complaints (physical complaints) of headaches, stomachaches, joint and muscle aches and pains, and visual disturbances without any physical cause is depression until proven otherwise. The depressed young person complains of poor energy and tiredness. A change in appetite (either a loss in appetite or excessive desire to eat) associated with change in weight is less common in children than adults, but is still symptomatic of depression.
It is important to understand that depression, as a disease or illness, is a group of symptoms associated with maladaptation or worsening in usual performance in either the home, school, or play environments. Most depressed young people will be failing in school, will be difficult to live with at home, and will drop out of usual extra-scholastic pursuits. The depressed individual’s judgment deteriorates, interests wane, and failure occurs.
Minor depressions are identical to major depressive episodes in duration but involve fewer symptoms and less impairment. The Weinberg Criteria for depression defines severity of a depressive episode in relation to death wishes and suicidal ideation: mild (no death wishes), moderate (positive for death wishes or suicidal thoughts), and severe (positive for suicidal plans or suicidal attempts).
Using the Weinberg Criteria, the diagnosis of depression is established through interview of the individual and the primary caretaker. The criteria symptoms for depression must represent a change from the individual’s usual self or a worsening of the usual self, be present for more than three weeks, and be associated with poor performance and a worsening of adaptation (or failure) in one, two, or three environments - home, school (work), or play. A symptom is accepted as positive when at least one of the characteristic behaviors listed for that symptom category is present (Table 1). Dysphoric moods and self deprecation (deteriorated self-esteem) must be reported by the young person for these symptoms to be considered positive. The other eight symptom categories can be reported by either the individual or the primary caretaker.
Petti (1978; 1985) developed the Bellevue Index of Depression (BID) from the Weinberg Criteria. The BID offers a systematic interview approach to both the young patient and the caretaker and can be used for diagnosis of depression and assessment of the severity of the depressed state. The Diagnostic Inventory for Children and Adolescents (DICA) developed by Herjanic and Reich (1982) is a structured interview based upon DSM-III criteria for depression and other psychiatric disorders. It is administered to both the patient and the caretaker. The Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS-P) developed by Puig Antich and Chambers (1978) is a structured interview modified for children based upon the Research Diagnostic Criteria (RDC) for depression and other psychiatric disorders in adults. The Children’s Depression Rating Scale - Revised (CDRS-R) was developed by Poznanski and colleagues, in 1985, and modeled after the Hamilton Rating Scale for Depression for adults. It correlates with global ratings for depression.
It is possible to recognize young people at risk for depression through self-report instruments. The Weinberg Screening Affective Scale (WSAS) is a 56 item self-administered form requiring fourth grade reading ability (Appendix A) that takes less than five minutes to complete. The WSAS correlates with depressive illness in both outpatient and hospitalized depressed children and adolescents.
Two large populations of high school students have been studied for depression by self-report using the WSAS. The first study group consisted of 3,292 students in a large metropolitan urban school district, and the second population had 1,298 students from a rural middle-size college community school district. These two population studies (in which 96% of the students participated) demonstrated that about 14% of high school students manifest depression by self-report. Gender and ethnic group differences were evident. Hispanic females had the highest percentage of depression by self-report (22%), while white males (8%) had the lowest. Black students, white females, and Hispanic males were intermediate in the prevalence of depression. Three percent (3%) of the students related suicidal thoughts (“I think a lot about killing myself”) These studies concluded that depressive symptomatology is prominent in adolescents, large numbers of young people are actively depressed, and a significant number are at risk for suicide. The WSAS can be used for the screening of depression in young people and is a strong confirmation instrument in the clinical setting. Two other widely used self-report forms for depression are the Beck Depression Inventory (BDI) which has been used in adolescents and young adults and the Children’s Depression Inventory (CDI) developed by Kovacs in 1987 for ages 7-17 years.
Dysthymia is characterized by chronic long-standing depressive symptomatology with ebbs and flows in severity, periods each day of depressive moods (mixed days), occasional fully-depressed days, and an occasional depression-free day; but no prolonged well states. Periods of major depression are common in individuals with dysthymic disorder. Dysthymia limits functioning, performance, and enjoyment, but is not associated with the same degree of impairment that characterizes minor or major depressive episodes.
The onset of the dysthymic pattern is usually during the pre-school years (ages 2-5 years), with major or minor depressive episodes occurring later in elementary and secondary school years. School phobia with the start of school can be the presenting symptoms of a major depressive episode in the anxious dysthymic young child. The learning disabled dysthymic child will often develop a major depressive episode during the third or fourth grade school years associated with the increased stress of school tasks.
The hallmarks of mania (Table 2) are euphoria and hostile anger. Euphoria has two presentations: a) an elated mood with inappropriate feelings of well being, cheerfulness, giddiness, and silliness. However, it can also be b) the inappropriate denial of problems or symptoms despite behavior that is obvious to observers as inappropriate, disruptive, and destructive. The manic young person can be hyperactive, intrusive, destructive, or agitated, or display hostile anger, while at the same time reporting, “I have no problems or concerns.”
The irritability of mania is hostile anger, with ranting rages, driven impulsive destructiveness, or uncon-trollable antisocial behavior. The hostile anger of mania can lead to homicidal wishes, thoughts, threats, or attempts.
Utilizing the criteria established by Weinberg and Brumback (1976) for the recognition of mania in children and adolescents, the individual must manifest either euphoria or hostile anger with three or more of the following six symptoms:
hyperactivity (mental, motor, or sexual), motor drivenness, intrusiveness;
push of speech;
flight of ideas, racing thoughts, the inability to maintain thinking on one idea;
grandiosity with heightened self-worth, self-power, and self-influence which can be delusional;
sleep disturbance with decreased need for sleep and nighttime hyperwakefulness (night-owl insomnia);
shortened attention span, inability to concentrate, and distractibility.
Each symptom must be a discrete change from the individual’s usual self, either a new behavior or a worsening of an old behavior. Although the original criteria stated that this symptom complex must be present for more than one month, further studies indicate that a duration of only one week is necessary.
Diagnosis of mania is established by interview and observation of the young person and interview with the primary caretaker utilizing a semi-structured, closed-end interview technique. A symptom is accepted as positive when at least one of the characteristic behaviors listed for the category is present. Euphoria (most commonly denial of any problems) must be reported by the individual, but the other symptoms are observational and can be reported by the individual, the caretaker, or knowledgeable others.
The course of childhood onset classic manic-depressive disease is exemplified by the child with no previous disturbance of mood and affect who begins to manifest the symptom complex of depression. On a rare occasion, a manic episode will precede the first period of depression. Subsequently there are discrete periods of depression usually lasting six to eighteen months and mania persisting for one to six weeks, with interspersed prolonged well states. Although classic manic-depressive disease is uncommon in pre-pubertal child-ren, the patterns of dysthymia, hypomania, cyclo-thymia, and juvenile rapid cycling bipolar disorder often begin during pre-school years, and are mislabeled as attention deficit hyperactivity disorder (ADHD), conduct or oppositional defiant disorder, and over-anxious disorder. As the child ages, classic manic-depressive disease becomes evident.
One of the confusing problems in the recognition and appropriate management of mania in children and adolescents is the observation that hypomania is chronic with a very early onset. Hypomania can present in utero as a hyperactive fetus; as overly alert, irritable, colicky infant with poor sleep habits; or as a “supermarket toddler” requiring restriction in the gro-cery store cart. The hypomanic child progresses through preschool years with significant hyperactivity, excessive cheerfulness, frequent sexual naughtiness, inappropriate silliness, giddiness, and elation, and nightowl insomnia. As the child ages, periodic rants, rages, hostile anger (mania), and even homicidal threats limit the hypomanic child’s ability to function. Hypomania is a common cause of attention deficit disorder with persistent hyperactivity (ADHD): “hypomanic/hyperactivity.” Increasing manic moods and classic manic-depressive disease become apparent as the child ages.
Cyclothymia is long-standing
(chronic) hypomania with moments per day of both depressive moods and “mini”
moments of significant anger. Most of the days are “mixed days” with an
occasional all “bad” day, but rarely an “all good day.” The cyclothymic
disorder begins in the toddler or early pre-school years and progresses during
late childhood and young adolescent years to discrete periods of major
depression or manic episodes.
The term juvenile rapid cycling bipolar disorder (JRCBD) is applied to a group of manic-depressive young people who are free of continuous hypomanic/hyperactivity but manifest moment-to-moment, day-to-day (“all mixed days”) of depressive moods, actions, and feelings interspersed with hostile anger, ranting, or rages. Juvenile rapid cycling bipolar disorder most often is evident during preschool years and worsens with aging to major depressive or manic episodes during the adolescent years.
The pattern of affective illness in the young person predicts family history. If the pattern in the young person is discrete cycles of depression with or without a manic episode and with prolonged well states, the family history will only be positive for typical depression or classic manic-depressive disease. Dysthymia or cyclothymia in the young person predicts a family history of depression or manic-depressive disease along with alcoholism.
Depressed children, who are oppositional and defiant or have a conduct disorder, have a positive family history of sociopathy, or alcoholism, along with depression or manic-depressive disease. Hallucinations during depression indicate a family member with schizophrenia. Depressed children with prominent somatic complaints frequently have a female family member with Briquet’s syndrome (a disorder characterized by severe hypochondriasis and often multiple operations without recognizable underlying medical disease). Inherited traits of these other disorders become apparent as additional symptoms during the depressive episodes in young people. When that young person is free of depression or manic-depressive episodes, those traits become inapparent. Thus, it is important to try to identify an underlying depression or manic-depressive state in any children presenting with an apparent conduct disorder, somatic complaints, or other behavior complexes.
It is also noteworthy that 30-40% of affectively ill children will have a biologic parent who is also affectively ill (most commonly depression) at the time the young person presents for initial evaluation.
The neurologic examination is very important in both establishing and understanding the localization of depression in the brain and the influence of this metabolic (chemical) disorder of the brain on other brain functions. During a depressive episode the young person will often manifest neurologic abnormalities of tone, posture, or reflexes in the left arm and leg indicating dysfunction of the right side of the brain (right cerebral hemisphere). The manic young person will have similar neurologic abnormalities that involve the right arm and leg indicating dysfunction of the left side of the brain (left cerebral hemisphere). Depressed young people have a variety of problems that indicate disturbances in right parietal lobe functions: they have impaired coordination and are clumsy (dyspraxias); handwriting deteriorates (dysgraphia); they have language skills (“math”), wit, and humor suffer. In mania, the individual demonstrates errors indicative of left cerebral hemisphere dysfunction: specific word finding (naming) difficulties, problems with clarity of speech, and abnormal verbalizations. During well states, these motor findings and disturbances of higher brain communicative-cognitive functions improve to the individual’s more usual abilities. An important concept is that affective illness can cause a learning disability or worsen an underlying learning disability.
The right posterior parietotemporal cortex appears to be involved in the production of the dysphoric and vegetative symptoms of depression. The left mesial temporal and entorhinal cortex appears to be responsible for the key symptoms of mania: euphoria (denial) and hostile anger. It is likely that obsessions, compulsions, and oppositional defiant behavior are minor manifestations of the hostile anger of mania. It is prudent to mention that some research concerning adult stroke patients has implicated left frontal lobe lesions in depression and right frontotemporal lesions in mania. However, studies by Freeman and colleagues (1985) and the preponderance of studies reviewed by Brumback (1985: 1993), indicate that the right parietotemporal area plays a major role in the genesis of depression. Our ongoing observations of children and adolescents confirm this brain localization for depression.
Biological correlates for depression in young people are similar to those reported in adults (Table 3). The most reproducible have been abnormalities of sleep and disturbances in hypothalamic-pituitary hormonal activity (abnormal dexamethasone suppression test and blunted growth hormone and thyrotropin releasing hormone). The strongest biological correlate is the proven successful treatment of depression with certain specific medications. Originally, the monoamine (MAO) inhibitors, and for the past twenty five years, the tricyclic antidepressant medications (TCAs) have provided beneficial therapy. Both these agents augment the activities of the neurotransmitters norepinephrine and serotonin. Serotonin is produced by neurons in the raphe nuclei of the brain stem and travels up the axons of these neurons to the cerebral hemispheres, more right than left, where it is released into the synaptic clefts. Norepinephrine is produced by another group of nerve cells, the locus ceruleus, of the brain stem and also travels up axons to the cerebral hemispheres. In depressed states, there is a relative deficiency of these two neurotransmitters. The tricyclic antidepressants, amitriptyline (Elavil) and doxepin (Sinequan), block the inactivation of serotonin thus allowing this neurotransmitter to be available for needed use by cerebral cortical nerve cells (Table 4). Desipramine (Norpramin) and protriptyline (Vivactil) block the inactivation of norepinephrine, while nortriptyline (Pamelor) and imipramine (Tofranil) prevent inactivation of both serotonin and norepinephrine. The second generation antidepressant trazodone (Desyrel) prevents inactivation of serotonin and maprotiline (Ludiomil) prevents inactivation of norepinephrine. The new third generation antidepressants sertraline (Zoloft), fluoxetine (Prozac), and paroxetine (Paxil) are very specific in preventing inactivation of serotonin. The underlying mechanisms leading to this relative deficiency of serotonin and norepinephrine in the cerebral cortex is unknown, but we believe that a dysfunction of modulating control from the right posterior temporoparietal cortex initiates a cascade of events causing altered activity of the key brain stem neurons and consequent deficiency of norepinephrine and serotonin release by their axons in the cerebral cortex.
The biology of mania (Table 3) is less well understood and cannot be explained by any available bioamine (neurotransmitter) theory. The major tranquilizers widely used to treat mania in adults block the effect of the neurotransmitter dopamine. However, the disorder of absent dopamine, e.g., Parkinson’s disease, is not characterized by mania. due to the severe progressive motor problems associated with the major tranquilizers, we actively avoid their use in young people). The two most successful drugs in the treatment and prevention of manic episodes, lithium carbonate and carba-mazepine (Tegretol), have many different biological actions, none of which are unique to mania. Although, right limb motor abnormalities, suggesting left brain dysfunction, is a reproducible observation, various brain imaging studies have been inconclusive, possibly due to heterogeneous study populations.
Concurrent diagnoses (a combination of two or more diagnoses occurring in the same individual at the same point in time) are common in young people with affective illness. There is a high prevalence of specific learning disabilities, overanxious disorder, school phobia, and anorexia in depressed young people. Conduct disorder and oppositional defiant disorder are common in children with hypomania, cyclothymia, or juvenile rapid cycling bipolar disorder.
It has been reported (and we concur) that 35-45% of delinquent adolescents have affective illness prior to their incarceration for delinquent activity. In this same context, drug-abusing, learning-disabled adolescents frequently have had major depressive episodes, chronic minor depression (dysthymia), or long-standing cyclothymia prior to initiating drug abusing behavior in adolescence. It has also been reported (and we concur) that at least 50% of the older adolescent and young adults committing suicide, with a prior history of drug abuse, had evidence of depression predating the abuse of drugs and suicide.
Nearly twenty years ago (1977), we reported that hyperactivity beginning after age two years was most often symptomatic of an underlying depression. Fifty-five percent (55%) of hyperactive pre-pubertal children were only hyperactive when in a state of depression (Table 5). The so-called “rebound” side effects and vegetative symptoms (loss of appetite, insomnia) attributed to stimulant medications used to treat hyperactive children are actually the result of an underlying depression.
The terms “hyperkinetic impulse disorder” (1950s), “minimal brain dysfunction” (MBD;1960s), “hyper-active child syndrome” (1970s), “attention deficit disorder with or without hyperactivity” (ADD with or without H; 1980s) and now “attention deficit hyperactivity disorder” (ADHD;1990s) have suc-cessively been applied to a heterogeneous (mixed) group of children, adolescents, and young adults whose clinical problem can be more correctly explained by one or more of the following disorders: affective illness, learning disabilities, and primary disorder of vigilance (Table 6). ADHD is just a group of symptoms that demands more accurate evaluation and correct diagnosis (Figure 1).
The recently described primary disorder of vigilance (PDV) (Table 7) is the proper diagnosis of a large group of young people fulfilling criteria for ADHD without hyperactivity or with only minimal hyper-activity. These young people are busy, inattentive, and daydream while trying to stay awake due to difficulties remaining alert (hypovigilance). The individual with primary disorder of vigilance, when depressed, becomes excessively sleepy and can “sleep the depres-sion off.” Such individuals can go to bed for weeks, months, or until the depression lifts. Interestingly, during a manic episode, the individual with primary disorder of vigilance continues to have vigilance problems (“sleepy”) when trying to concentrate.
Children, adolescents, and young adults with specific learning disorders have a high prevalence of depression. Sixty to eighty percent (60-80%) of learning disabled children failing in school will fulfill criteria for depression at the time of initial clinical evaluation. Evaluation of individuals failing in school necessitates careful assessment of emotions and cognition and communication skills (higher brain functions; Table 8), along with standard neurologic and physical examinations. This total evaluation, including history of the present problem, developmental, health and family histories should take less than 90-120 minutes to complete. Too often an evaluator takes the short-cut of only evaluating part of the young person rather than the whole person: the evaluation for learning disability will be omitted; affective illness will be excluded; none of the young person’s brain functions will be examined (with only a motor examination performed); or without any examination, the determination will be made that the environment (home or school) is the sole cause of the difficulties; or the label ADHD suggested and a prescription of stimulant medication offered. It is important to undertake a complete systematic evaluation to establish correct diagnosis and develop a successful clinical management program.
For children, adolescents, and young adults with learning disabilities, school can be an unpleasant, noxious, and highly frustrating environment. Young people with various specific learning disabilities often manifest poor attention, restlessness, daydreaming, and limited diligence when asked to do tasks that they are unable to do. It is postulated that continuous stimulation of a genetically maldeveloped area of the cerebral hemisphere makes that area, surrounding cerebral cortex, and homologous cerebral cortex in the opposite hemisphere all work less well. For example, language-impaired and dyslexic children (left hemisphere learning disability) often become moody, irritable, and angry when asked to speak, read, or recall words. Poor spellers (left hemisphere learning disability), practicing spelling for the spelling test, become increasingly dysphoric, anxious, irritable, and dysattentive as the school year progresses. Some will cry, show poor self-esteem and express death wishes. The repeated attempts to perform language functions by these children stimulates poorly functioning left cere-bral hemisphere which leads to dysfunction of the opposite right hemisphere areas with resultant depressive symptomatology. These examples represent the interaction between environmental stress and cerebral dysfunction.
Right hemisphere
learning-communication disorders (RHD) are characterized by difficulties with
social communication including social discomfort, social dysemotionality,
dysprosody (difficulties understanding the gestures or speech tones of others,
difficulties expressing appropriate gesture or speech tones, or both),
ordering problems (difficulties with sequencing, timing, and context), motor
and social dyspraxias (clumsiness), disturbed attention (both hypovigilance
and neglect), difficulties with calculation (dyscalculia for the sequencing of
numbers), and poor graphic skills (Table 8). Young people with right
hemisphere learning communication disorders, during adolescence and adulthood,
are at high risk for major depressive disorder often exacerbated by the
inappropriate stress promoted by education directed at their communication
difficulties. This population can be divided into an
under-expressive group (hypoprosodic; developmental expressive
hypodysprosodia) and an over-expressive group (Asperger’s Syndrome;
developmental expressive hyperdysprosodia).
In contrast, it is uncommon to see on a referred basis a pure left hemisphere learning disability (Table 8). Most, if not all, children, adolescents, and young adults referred because of school failure have evidence of bihemispheral (right and left cerebral hemisphere) learning disorder. With sixty percent (60%) or greater of these bihemispheral learning disabled children manifesting affective illness, it is often the exacerbation of the affective illness that tips the balance from marginal passing to failure. Within this context, there are several major questions: “Why is this young person now depressed? Can depression be induced or promoted by asking the right cerebral hemisphere to do repetitively what it is unable to do? Is it likely that pure left hemisphere disorders (pure ‘classic’ dyslexia; pure ‘classic’ dysphasia) (Table 8), with no genetic basis for depression, will struggle in the school setting but be free of depression? (Population studies of non-referred young people suggest this interpretation). Does asking the learning disabled individual to work repetitively at tasks he or she is unable to do cause depression? Is there a biological basis for a ‘reactive’ depression?”
The multiple threshold theorem best explains induction of affective illness. For those individuals with a high genetic load for depression little or no environmental stressors are needed. These individuals will have spontaneous episodes of affective illness throughout their lives. In contrast, for those individuals with a low genetic load, external factors are important in the induction of a depressive or manic episode. Such episodes can be induced by head trauma, viral encephalitis, medical illnesses (including hyper-thyroidism, systemic lupus erythematosus, and infectious mononucleosis), and various drugs and medications (including minor and major tranquilizers, anti-hypertensives, and anti-convulsants). Inappropriate educational stress (as indicated above) can also induce depression. Young people with specific learning disabilities who are failing in school and functioning poorly outside of school must be considered to have depression until proven otherwise. The treatment of specific learning disabilities should avoid induction of depression or worsening of other patterns of affective illness by providing an appropriate educational environment. If manic or depressive episodes occur, specific medical management should be undertaken (Table 9).
Depression and other patterns of manic-depressive disease are chemical disorders of the brain that can occur spontaneously or be promoted or induced by other medical illnesses, drugs and medications, and environmental events. Often the school environment is a major stressor for the learning disabled individual. Treatment strategies for learning disabled young people should address appropriate educational input/output systems assuring success in school, including college preparatory and college classes. The goal of formal education must be the acquisition and utilization of meaningful information and the pursuit of the individual’s assets, talents, and creativity. The educator provides a structured and disciplined environment to accomplish these goals. Reading, spelling, numeric language, graphic skills, vocabulary, and word usage improve with aging and maturation of the nervous system, something that cannot be accelerated by remediation or other programs. Young people with specific learning disabilities are willing, able, capable, and competent learners if appropriate input/output systems are used. Table 10 summarizes the bypass/ compensatory strategies and assistive technologies that must be implemented for the learning disabled person to prevent the induction of affective illness episodes.
The management of children, adolescents, and young adults with affective illness is multimodal (Table 9). They must be informed about the nature, course, and treatment of this disease. The environments must be supportive and reassuring. There must be an emphasis on positive interaction, and the individual must be assisted with appropriate decision making. The depressed young person should not be allowed to “drop out” of usual pursuits.
Cognitive coaching on a “mini” daily basis should be offered by parents and significant others (teachers, coaches, employers, or friends). Cognitive coaching involves recognizing that actions should dictate feelings and intelligence should overrule emotions: “It is not how one feels but it is how one acts”; “act positive-feel better”; “feel sad and act sad, then you will be sad”; “feel sad and act happy, then you will feel better”; “feel mad and act with anger, trouble!”; “feel mad and act civil, then good things can happen”. Clinical cognitive psychological counseling may be indicated for both the individual and the primary caretakers (Wilkes and colleagues, 1994). The emphasis is for all concerned parties to act using intelligence and not emotions, with such interaction being positive, rewarding, reassuring, and supportive, while intelligently ignoring the disturbing mood or emotion.
The hallmark of successful treatment is for the brain to be free of the “chemical imbalance” of affective illness. For this to occur, the treatment should include appropriate medication management. Prior to instituting antidepressant medication, it has become standard to obtain an electrocardiogram (EKG). Complete blood count with differential, blood chemistry profile, and thyroid profile are also often indicated (particularly before use of antimanic drugs). An electroencephalogram (EEG) is obtained if the person has had a seizure in the past, if there is a positive family history for epilepsy, or prior to the use of antimanic drugs. Sometimes an EEG, CT scan, or MRI is indicated as a result of abnormal neurologic findings.
The drug management of depression, dysthymia, and cyclothymia with prominent dysphoria continues to be with the first generation antidepressants (tricyclic antidepressants) in children and young adolescents. The choice of drug is dependent upon the body type of the individual and prior treatment response in family members. Amitriptyline (Elavil) is the first choice in young people who are not overweight. If not effective, this is followed by doxepin (Sinequan). These two medications increase appetite and can increase weight. Imipramine (Tofranil) followed by desipramine (Norpramin), the metabolite of imipramine, are the first drugs in overweight young people. Nortriptyline (Pamelor), the metabolite of amitriptyline (Elavil), is sometimes the third choice but can also cause excessive weight gain. If the depressed child or young adolescent does not respond to the above medications, the third generation antidepressants are then offered. For most, we use fluoxetine (Prozac) first, followed by sertraline (Zoloft).
In mature adolescents and young adults with depression, dysthymia, and cyclothymia with prominent dysphoria, the third generation antidepressants are becoming the first choice rather than the tricyclic antidepressants. For those free of prominent hypomania or manic moods, we prefer fluoxetine (Prozac), followed by sertaline (Zoloft) and then either imipramine (Tofranil) (a first generation antidepressant), or paroxetine (Paxil). Adolescents manifesting dysthymia with bipolar features, juvenile rapid cycling bipolar disorder, or cyclothymia are initially offered imipramine (Tofranil) followed by sertaline (Zoloft), prior to antimanic medication.
For successful management of depression and dysthymia in adolescents and young adults, a combination of a third generation antidepressant and a tricyclic is often needed. The third generation antidepressant is taken in the morning and the tricyclic at bedtime.
Table 11 lists the antidepressant medications, the dosage range, serum levels, indications, contrain-dications, and potential adverse effects. These medications are not approved by the FDA for use in children less than 12 years of age, except for the use of imipramine for bedwetting. However, they are successful in the treatment of depression in all ages and their use has become a standard of practice.
There is a group of depressed learning disabled young people who also have inherited the primary disorder of vigilance (Table 7). If this group fails with the above approach to drug management, protriptyline (Vivactil) is sometimes successful. Occasionally a combination of protriptyline during daytime hours with another tricyclic antidepressant at bedtime proves beneficial.
The treatment of mania in classic manic-depressive disease, juvenile rapid cycling bipolar disorder, and cyclothymia will often require antimanic drugs (Table 12). However, we continue to offer individuals with these patterns of affective illness an initial trial of antidepressant medication. If manic symptomatology is promoted then antimanic medication must be started. The antimanic drugs primarily used are carbamazepine (Tegretol) and lithium carbonate. If the manic state is characterized primarily by hypomania and elated moods, then lithium is the first choice. If the mania is manifested as hostile anger without elation, the first antirnanic drug is carbamazepine. Most individuals whose mania is successfully controlled with lithium (or carbamazepine) will require the addition of an antidepressant medication to be free of depression.
All the antidepressants can promote or induce mania Likewise, the antimanic drugs can promote depression. For most depressed individuals, an antidepressant medication will be successful. For some the addition of lithium or carbamazepine with the antidepressant will be needed to achieve stable moods and good functioning.
Serum medication levels are obtained during the course of treatment. Repeat EKG, blood chemistries profile, and thyroid profile are performed at appropriate intervals depending upon the medication being used and age of the patient.
Frequently the young patient (and parents) will ask: “Do I have to take medicine forever?” Our answer is “No.” Once a well state is established for a period of 6-9 months, medication can be tapered on a trial basis. Although affective illness is a cyclic disorder, recurrent cycles can be expected but not anticipated or predicted. Sometimes recurrence will be seasonal and on other occasions associated with stressful events. If, with aging through adolescence, the dysthymia, hypomania, cyclothymia, or rapid cycling bipolar disorder patterns do not stabilize, then appropriate medication will be needed for a long period of time: “But nothing is forever.” However, individuals requiring and benefiting from lithium can anticipate long term use of the medication.
A complex issue is the treatment of attentional symptoms with the two stimulant medications: methyl-phenidate (Ritalin) and pemoline (Cylert). These two agents heighten vigilance and can be successfully used in the management of the primary disorder of vigilance. They also lower the hyperactivity of hypomania (Table 12). However, these drugs can promote depression. The mood disturbance (“rebound”), insomnia, and loss of appetite associated with these two medications are symptomatic of an underlying depression. Rarely are these two agents helpful in the management of affectively-ill, learning-disabled young people. With aging and freedom from depression, those with the primary disorder of vigilance will stay busy to be alert, to learn, and to perform. If depression occurs, appropriate antidepressant medication should lift the depression thus restoring normal vigilance which was worsened by the depression.
A common cause of school failure in learning disabled young people is affective illness. Depression is generated by the right cerebral hemisphere and manic symptoms by the left hemisphere. Affective illness is a genetic disorder that can present in several patterns: depression, dysthymia, mania, hypomania, cyclothymia, juvenile rapid cycling bipolar disorder, and classic manic-depressive disease. The treatment is multimodal involving the use of appropriate medication in addition to appropriate environmental (home and school) communication systems, cognitive coaching, and counseling. Affective illness is recognizable, treatable, and should have a good prognosis.
Acknowledgments: This work was funded by contribution from Caleb C. and Julia W. Dula Educational and Charitable Foundations, Mr. and Mrs. Woody Hunt, Mr. and Mrs. Morton Meyerson, and Mr. and Mrs. Jerrold Trim.
Reprint requests to: Warren A. Weinberg, MD., Exchange Park, 6303 Forest Park, Suite 13.350, Dallas, TX 75235
From Secondary Education and
Beyond, LDA, 1995
Table 1. Childhood Depression
A. The presence of both symptoms I and II and four or more of the remaining eight symptoms (III-X):
I. Dysphoric mood*
(statements of sadness, loneliness, unhappiness, hopelessness, pessimism;
mood swings, moodiness,
irritable, easily annoyed; cries easily, hypersensitive; negative; difficult
to please
II. Self-deprecatory ideation*
(feelings of being worthless, useless, dumb, stupid, ugly, guilty; beliefs of
persecution; death wishes;
suicidal thoughts and/or attempts)
III. Agitation*
(difficult to get along with; quarrelsome; disrespectful of authority;
belligerent, hostile, agitated; excessive fighting or sudden anger)
IV. Sleep disturbance
(initial, interval, and/or terminal insomnia; difficulty awakening in the
morning)
V. Change in school performance*
(frequent complaints from teachers: “daydreaming, poor concentration, poor
memory;” loss of usual effort in school subjects; loss of usual interest in
nonacademic school activities; incomplete classroom assignments; much
incomplete homework; drop in usual grades; finds homework difficult)
VI. Diminished socialization*
(less group participation; less friendly, less outgoing; socially withdrawing;
loss of usual social interests)
VII. Change in attitude toward school*
(does not enjoy school activities; does not want or refuses to attend school
VII. Somatic complaints
(nonmigraine headaches; abdominal pain; muscle aches or pains; other somatic
concerns)
IX. Loss of usual energy
(loss of usual personal interest or pursuits other than school; decreased
energy, mental and/or physical
fatigue)
X. Unusual change in appetite and/or weight
(anorexia or polyphagia; unusual weight change in past 4 months)
B. Interview of patient and primary caretake (historians) is conducted utilizing a semistructured closed-end technique.
C. A symptom is accepted as positive when at least one characteristic behavior listed in braekets for the category is present.
D. Symptoms I and II must be reported by the patient to be considered
positive, but symptoms III to IX to be
considered positive can be reported by either patient or historian.
E. Each symptom must be discrete change in usual self (new or worsening of old behavior); symptom complex must be present for more than 1 month and associated with maladaptation.
*Denotes psychological symptoms
Adapted from Levy HB, Harper
CR, Weinberg WA: A practical approach to children failing in school.
Pediatr Clin North Am 39:895-928, 1992 and Weinberg WA, Rutman J, et al:
Depression in children referred to an
educational diagnostic center: Diagnosis and treatment. J Pediatr
83: 1065-1072, 1973
Table 2. Childhood Mania
A. The presence of either or both symptoms 1 and 2 and three or more of the remaining six symptoms (3-8):
1. Euphoria
(denial of problems or illness: “nothing wrong with me”, inappropriate
feelings of well-being, inappropriate cheerfulness, giddiness, silliness)
2. Irritability and/or agitation
(belligerence: hostile anger; destructiveness: inappropriate crudeness,
rudeness. vulgarity)
3. Hyperactive, “motor driven,” intrusive/disruptive
4. Push of speech (may become unintelligible), garrulousness, “motor-mouth”
5. Flight of ideas (racing thoughts)
6. Grandiosity (may be delusional)
7. Sleep disturbance (decreased sleep)
8. Distractibility, shortened attention span, inability to concentrate
B. Interview of patient and primary caretakers (historians) is conducted utilizing a semistructured. closed-end technique.
C. A symptom is accepted as positive when at least one of the characteristic behaviors listed for the category is present.
D. Symptom 1 must be reported by the patient to be considered positive, but symptoms 2 to 8 to be considered positive can be reported by either patient or historian.
E. Each symptom must be discrete change in usual self (new or worsening of old behavior); symptom complex must be present for more than 2 weeks and associated with change to maladaptation.
Adapted from Levy HB, Harper
CR, Weinberg WA: A practical approach to children failing in school.
Pediatr Clin North Am 39:895-928,1992 and Weinberg WA, Brumback RA:
Mania in childhood: Case studies and
literature review. Am J Dis Child 130:380-385. 1976.
Table 3. Biological Correlates
Depression
Abnormal neuroamine metabolism
Sleep rhythm disturbance
Early-onset REM sleep
Fragmented stage IV sleep
Aberrant neuroendocrine secretion
Nonsuppressible cortisol secretion
Blunted thyrotropin release following TRH
Blunted growth hormone release
Abnormal left limb electrodermal response
Left limb motor hemisyndromes
Right cerebral (parietal) cognitive dysfunction
Hypovigilance
Right cerebral hypometabolism
Response to neuroamine re-uptake blocking drugs
Mania
Abnormal neuroamine metabolism
Right limb motor hemisyndromes
Left cerebral cognitive dysfunction
Response to dopamine receptor blocking drugs
Response to lithium
Primary Disorder of Vigilance
Left limb motor hemisyndromes
Hypovigilance
Hypersomnolence
Narcolepsy
Inappropriate REM-onset sleep activity
Hypovigilance
HLA-DR2 phenotype
Learning Disability (Right Hemisphere)
Subtle left limb hemiatrophy
Left limb motor hemisyndromes
Right cerebral hypometabolism
Sociopathy
Absence of cognitive dysfunction
Absence of parietal-temporal dysfunction
Absence of motor abnormalities
Learning Disability (Left Hemisphere)
Subtle right limb hemiatrophy
Right limb motor hemiatrophy
Left cerebral hypometabolism
Adapted from Weinberg WA, Brumback RA: The myth of attention deficit hyperactivity disorder: Symptoms resulting from multiple etiologies. J Child Neurol 7:431 445, 1992.
Table 4. Summary of Pharmacologic
Differences
among Six Tricyclic Antidepressants
Anticholinergic Block of Amine Pump
Drug Sedation Effects Serotonin Norepinephrine
Imipramine ++ ++ ++ ++
Amitriptyline +++ +++ +++ +
Desipramine + + 0 +++
Nortriptyline ++ ++ + ++
Doxepin +++ +++ Weak
Protriptyline 0 ++ Not known
0 = none; + = slight; ++ = moderate; +++ = high
Adapted from Holister LE: Drug therapy: Tricyclic antidepressants, N Engl J Med 229:1106-1109, 1168-1171, 1978 and with permission in Weinberg WA, Emslie GJ: Attention deficit hyperactivity disorder: The differential diagnosis. J Child Neurol 6(Suppl):S23-S36, 1991.
Table 5. Consecutively Referred Normally
Intelligent
Learning Disabled Prepubertal Children
Diagnosis Number/Total (%)
Total with hyperactivity 117/223 (52.5)
Not depressed 31/117 (26.0)
Positive for depression 86/117 (74.0)
Hyperactive only while depressed 64/117 (55.0)
Total with depression 136/223 (61.0)
Not hyperactive 50/136 (37.0)
Hyperactive 86/136 (63.0)
Hyperactivity plus depression 86/223 (38.5)
Adapted from Weinberg WA,
Emslie GJ: Attention deficit hyperactivity disorder: The differential
diagnosis.
J Child Neurol 6(Suppl):S23-S36, 1991 and Brumback RA, Weinberg WA:
Relationship of hyperactivity and depression in children. Percept Mot
Skills 45:247-251, 1977.
Table 6. Prominent Causes Of Attention Deficit Hyperactivity Disorder
DEVELOPMENTAL HYPERACTIVITY
AFFECTIVE ILLNESS (BIPOLAR DISORDER)
Dysthymia
Hypomania
Cyclothymia
Depression
Mania
Classic manic-depressive disease
Juvenile rapid cycling bipolar disease
PRIMARY DISORDER OF VIGILANCE
LEARNING DISABILITIES (task dependent)
NARCOLEPSY
PRIMARY CONDUCT DISORDER
CLASSIC FOCAL NEUROLOGICAL DEFICIT
Neglect
Inattention
Adapted from Weinberg WA,
Emslie GJ: Attention deficit hyperactivity disorder: The differential
diagnosis.
J Child Neurol 6(Suppl):S23-S36, 1991.
Table 7. Primary Disorder of Vigilance
A. A disorder of at least I year duration with symptoms from all five major symptom categories:
1. Decreasing ability to sustain alertness, wakefulness, arousal, and watchfulness during continuous mental (or other task) performance
a. Complaints of tiredness, drowsiness, sleepiness, lethargy
b. Yawning, stretching, sleepy-eyed (glassy-eyed) appearance
c. Falling asleep; excessive napping
2. Decreasing attention to present activities
a. Daydreaming
b. Difficulty focusing attention; loses place in activities and conversation
c. Poor performance
d. Slow, delayed, or incomplete tasks
e. Disorganized
3. Avoidance of structured or repetitive activities
a. Loss of interest in or complaint that structured activities are dull,
boring, monotonous, tedious,
uninteresting (or no longer interesting)
b. Preference for shifting activities that have random or irregular
changes in schedule or activity
(orderly randomization)
4. Motor restlessness and behaviors to improve alertness
a. Fidgeting
b. Talkativeness
c. Moving about
d. Busyness
5. Caring, compassionate, affectionate, kind temperament
B. A major symptom category is accepted as positive when the symptom or one
or more of its behaviors is
identified in a semi-structured, closed-end interview of patient and primary
caretakers (historians).
C. This symptom complex must precede the onset of other medical disorders (including depression, narcolepsy, various medications, alcohol and drug abuse, hypothyroidism) that can cause secondary hypovigilance.
D. Although symptomatology may be identified at any age, the disorder generally becomes more symptomatic with schooling and aging and can result in increasing maladaptation.
Adapted from Weinberg WA, Brumback RA Primary disorder of vigilance: A novel explanation of inattentiveness, daydreaming, boredom, restlessness. and sleepiness. J Pediatr 116:720-725, 1990 and Weinberg WA and Harper CR: Vigilance and its disorders. Neurol Clin 11:59-78, 1993.
Table 8. Left And Right Cerebral Hemisphere
Functions
Left Cerebral Hemisphere Functions
Left Parietal Temporal Cortex
Primary Sensory Functions
Sensation of right body
Perception of right visual field
Appreciation of sound from right ear
Cognitive Functions
Language Skills: Comprehension and expression of oral and written language including storage and recall of symbols and nominals; storage of common nouns and action verbs (inner vocabulary); rules of grammar and structure of language; and verbal word recognition (inner speech)
Praxias - command type
Emotional Functions
Denial, oppositional, non-compliance, and hostile anger (mania)
Obsessions and compulsions
“Learned” pessimism and negativity
Pedantic, rigid responses
Rationalization
Attentional Functions
Attentiveness to right space
Minor role in vigilance (tonic state)
Left Frontal Lobe Functions
Fundamental movement of right body
Right voluntary gaze
Clarity of verbal thought (freedom from auditory-verbal hallucinations and delusions)
Adapted from Weinberg WA, Emslie GJ: Adolescents and school problems: Depression, suicide, and learning disorders. In Stiffman AR, Feldman RA (eds): Advances in Adolescent Mental Health, vol 3, Greenwich, CT, JAI Press, 1988 and Weinberg WA, Harper CR, Brumback RA: Use of the Symbol language and communication battery in the physicians office for assessment of higher brain functions (particularly the temporal and parietal lobes). Child Neurol 1995; 10(Suppl 1): 233-S31.
Right Cerebral Hemisphere Functions
Right Parietal Temporal Cortex
Primary Sensory Functions
Sensation of left body
Perception of left visual field
Appreciation of sound from left ear
Cognitive Functions
Spatial orientation
Spatial relations (right-left discrimination)
Sequencing of symbols, objects, and events
Timing and time perception
Music appreciation
Recognition of objects and faces
Geometric communication
Non-verbal communication
Praxias - coordinated motor behavior
Emotional Functions
Prosody
Primary emotionality
Empathy and comprehension of emotionality
Affective behavior (depression)
Wit and humor
Attentional Functions
Arousal
Vigilance: alertness - wakefulness (phasic states)
Attentiveness: Right and left space
Primary Visual Imagery
Picture-to-picture storage and representation
Symbolization (symbolic representation)
Picture-to-word storage and representation
(understanding the surrounding world)
Right Frontal lobe functions
Fundamental movement of left body
Left voluntary gaze
Motor persistence
Order (formal type: seeing the world as a
series of
interrelated entities)
Planning
Volition - intention (“the will”)
Diligence - work ethic - drive
Executive control
Abiding by rules and regulations: (social
conduct);
reputation
Table 9. Management of Children and Adolescents with Affective Illness
Individual, family, and environmental counseling
Remove inappropriate stressors: Use bypass strategies; demands and tasks in keeping with the young person’s facilities.
Informative: Emphasis on genetics, biology, and maturation with potential cycles.
Educative: Emphasis on what is known and not known; avoid rationalization and misinformation.
Supportive: Be a positive advocate.
Reassuring: A treatable and self-limiting condition with anticipation of long periods of well states.
Assist with order and planning: Toward school, work, play, and pursuit of assets and talents.
Assist with decision making “Continue usual pursuits”; “Do not drop out.” Cognitive coaching on a “mini” daily basis: “Learn to think positive — act positive.” “Come to know that actions should dictate feelings,” “Intelligence should overrule emotions.”
Psychopharmacologic treatment
Tricyclic antidepressants: Amitriptyline, imipramine, desipramine, nortriptyline, protriptyline, doxepin, clomipramine
Newer antidepressants: trazodone, maprotiline, fluoxetine, sertraline, paroxetine.
Thioridazine (and rarely haloperidol — other major tranquilizers are not presently being used).
Carbamazepine.
Lithium.
Adapted from Levy HB, Harper CR, Weinberg WA: A practical approach to children failing in school Pediatr Clin North Am 39:895-928, 1992; Weinberg WA, Emslie GJ: Attention deficit hyperactivity disorder: The differential diagnosis. J Child Neurol 6(Suppl):S23-S36, 1991; and Weinberg WA, Emslie GJ: Adolescents and school problems: Depression, suicide, and learning disorders. In Stiffman AR, Feldman RA (eds): Advances in Adolescent Mental Health, vol 3, Greenwich, CT, JAI Press, 1988, pp 181-205.
Table 10. Bypass Compensatory Strategies to
Reduce Stress
in Children with Cerebral Dysfunction
Problem Area Strategy
Reading 1. Listen to “good readers” read age-appropriate (not “skill” level) material while eyeing the printed page; avoid listening to poor readers reading
2. Use talking books, listen to tapes, and view films and filmstrips for information; if necessary, read salient material using well-prepared course handouts and worksheets.
3. Read silently for meaning, but never read aloud.
4. Test orally and provide a reader and recorder for necessary written tests (such as the college entrance examinations and group achievement tests).
Word
finding 1. Use picture-to-word matching
tasks (including associating names
and faces) for vocabulary development.
Reading comprehension 2. Test both orally and in writing using
multiple-choice, true-false, yes-no,
Picture-word association or circle-the-correct-answer formats; avoid both oral and written “fill-in the blank” testing situations.
Spelling 1. Look at word while simultaneously hearing the word spoken.
2. Test spelling by multiple-choice format using age-appropriate (not “skill” level) words.
3. Use The Bad Speller’s Dictionary (New York, Random House, 1974).
4. Use a good speller as a secretary or write using computer word processor with appropriate spell-checking software.
Writing 1. Encourage oral expression or demonstration instead of written tasks.
2. Allow the child to dictate information or answers into a tape recorder
or directly to
a secretary.
3. Use a circle-the-correct-answer written text format.
4. Provide computer with word-processing software that contains a built-in dictionary and thesaurus.
Computation 1. Pursue instruction of age-appropriate (not “skill level”) mathematical
concepts and Arithmetic Mathematics principles, avoiding specific calculations.
2 For instruction of computation, teach by example showing both correct
and
incorrect responses.
3. Provide calculators and/or computers with appropriate software to perform the necessary computations at age-appropriate (not skill”) level.
4. Utilize pick-the-correct-answer testing formats.
Organization 1. Offer one small task at a time, or divide larger tasks into several mini-tasks.
2. As necessary, provide reminders to child of tasks; avoid nagging and avoid checklists.
3. Avoid punishment for “forgetting,” not finishing, or being late with assignments or tasks.
4. Provide the child with a pictorial system for self-reminding of tasks, chores, and events.
5. Offer all testing using an untimed format.
Adapted from Levy HB, Harper CR, Weinberg WA: A practical approach to children failing in school. Pediatr Clin North Am 39:895-928. 1992 and Brumback RA, Weinberg WA: Pediatric behavioral neurology: An update of the neurologic aspects of depression, hyperactivity, and learning disabilities. Neurol Clin 8:677-703, 1990.
Table 11. Antidepressant Pharmacotherapy
Medication
Amitriptyline
Dosage Range
Children 1-3 mg/kg/d (up to 5 mg/kg/d if monitored)
Adolescents 110-200
Serum level (mg/ml)
100-250 (sum of
amitriptyline plus
nortriptyline)
Indications
Primary drug of choice for depression in non-obese preadolescents, or underweight adolescents, with a history of “pure familial” type of affective disorder
Tertiary drug for depression in adolescents or if family history of “depressive spectrum biogeny”
Contraindications
Obesity
Excessive daytime sleepiness
History of paroxysmal atrial tachycardia other cardiac conduction disturbances
Liver or renal disease
unless dose and serum levels can be closely monitored
Potential Adverse Effects
Induction or promotion of mania
Atropinic side effects
Mild tremor
Worsening of depressive symptoms
Increased appetite and excess
Excessive daytime sleepiness
Rash
EKG evidence of cardiac conduction changes +
Hypertension
Nortriptyline
(A metabolite of amitriptyline)
Children 1-3 mg/kg/d
Adolescents 50-150 mg/d
50-150
Secondary drug for depression in children and adolescents
History of paroxysmal atrial tachycardia or other cardiac conduction disturbances
Liver or renal disease unless dose and serum levels can be closely monitored
Same as amitriptyline except with less effect on appetite and weight
“Therapeutic window” in which sub-therapeutic dosages worsen depression
Imipramine
Children 1-3 mg/kg/d (up to 5 mg/kg/d if monitored)
Adolescents 100-200 mg/d
150-250 (sum of imipramine plus desipramine)
Primary drug of choice for depression in adolescents, obese children, or with a family history of “depressive spectrum biogeny"
Significantly under-weight or with anorexia
History of paroxysmal atrial tachycardia or other cardiac conduction disturbance
Liver or renal disease unless dose and serum levels can be closely monitored
Induction or promotion of mania
Atropinic side effects
Mild tremor
Worsening of depressive symptoms
Decreased appetite and excess weight loss
Excessive daytime sleepiness
Rash
EKG evidence of cardiac conduction changes
Hypertension
Table 11. Antidepressant Pharmacotherapy (Continued)
Medication
Dosage Range
Serum level (mg/ml)
Indications
Contraindications
Potential Adverse Effects
Desipramine (a metabolite of imipramine)
Children 1-3 mg/kg/d (up to 5 mg/kg/d if monitored)
Adolescents 100-200 mg/d
50-300
Primary or secondary drug of choice for depression in children and adolescents with excessive daytime sleepiness
Secondary drug for depression in adolescents, obese children, or with a family history of “depressive spectrum biogeny”
Same as nortriptyline